Moreover, a very recent study revealed that bones are the primary contributor to increased circulating LCN2 levels in HFD-induced obesity models is mainly contributed by bone, as this increase is lost following the deletion of LCN2 in osteoblasts (243). This evidence concerns the gene LCN2 and obesity disorder.